Moreover, despite CTLA4-Ig treatment did not impact STAT3 and STAT5 expression in peripheral blood-derived CD4pos cells in RA patients, their STAT3 and STAT5 expression was inversely correlated with CDAI value after 6 months of CTLA4-Ig treatment. This evidence concerns the gene CTLA4 and rheumatoid arthritis.